XML 25 R7.htm IDEA: XBRL DOCUMENT v3.23.2
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($)
$ in Millions
Total
Common Stock
Additional Paid-in Capital
Accumulated Retained Earnings
Accumulated Other Comprehensive Income
Beginning balance (in shares) at Dec. 31, 2021   120,000,000      
Beginning balance, value at Dec. 31, 2021 $ 1,988 $ 1 $ 1,630 $ 357 $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 51     51  
Activity related to share-based compensation 4   4    
Derivative instrument adjustments, net of tax 22       22
Ending balance (in shares) at Mar. 31, 2022   120,000,000      
Ending balance, value at Mar. 31, 2022 2,065 $ 1 1,634 408 22
Beginning balance (in shares) at Dec. 31, 2021   120,000,000      
Beginning balance, value at Dec. 31, 2021 1,988 $ 1 1,630 357 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 124        
Foreign currency translation adjustments (6)        
Ending balance (in shares) at Jun. 30, 2022   118,000,000      
Ending balance, value at Jun. 30, 2022 2,077 $ 1 1,626 424 26
Beginning balance (in shares) at Mar. 31, 2022   120,000,000      
Beginning balance, value at Mar. 31, 2022 2,065 $ 1 1,634 408 22
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 73     73  
Activity related to share-based compensation 16   16    
Employee stock plan issuance 2   2    
Foreign currency translation adjustments (6)       (6)
Derivative instrument adjustments, net of tax 10       10
Repurchase and retirement of common stock, net of tax (in shares)   (2,000,000)      
Repurchase and retirement of common stock, net of tax (83)   (26) (57)  
Ending balance (in shares) at Jun. 30, 2022   118,000,000      
Ending balance, value at Jun. 30, 2022 $ 2,077 $ 1 1,626 424 26
Beginning balance (in shares) at Dec. 31, 2022 113,628,706 113,000,000      
Beginning balance, value at Dec. 31, 2022 $ 2,151 $ 1 1,582 529 39
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 73     73  
Activity related to share-based compensation (in shares)   1,000,000      
Activity related to share-based compensation 3   3    
Derivative instrument adjustments, net of tax (10)       (10)
Repurchase and retirement of common stock, net of tax (in shares)   (2,000,000)      
Repurchase and retirement of common stock, net of tax (85)   (26) (59)  
Ending balance (in shares) at Mar. 31, 2023   112,000,000      
Ending balance, value at Mar. 31, 2023 $ 2,132 $ 1 1,559 543 29
Beginning balance (in shares) at Dec. 31, 2022 113,628,706 113,000,000      
Beginning balance, value at Dec. 31, 2022 $ 2,151 $ 1 1,582 529 39
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 153        
Foreign currency translation adjustments $ (10)        
Ending balance (in shares) at Jun. 30, 2023 109,929,447 109,000,000      
Ending balance, value at Jun. 30, 2023 $ 2,105 $ 1 1,541 539 24
Beginning balance (in shares) at Mar. 31, 2023   112,000,000      
Beginning balance, value at Mar. 31, 2023 2,132 $ 1 1,559 543 29
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net income 80     80  
Activity related to share-based compensation 16   16    
Employee stock plan issuance 4   4    
Foreign currency translation adjustments (10)       (10)
Derivative instrument adjustments, net of tax 5       5
Repurchase and retirement of common stock, net of tax (in shares)   (3,000,000)      
Repurchase and retirement of common stock, net of tax $ (122)   (38) (84)  
Ending balance (in shares) at Jun. 30, 2023 109,929,447 109,000,000      
Ending balance, value at Jun. 30, 2023 $ 2,105 $ 1 $ 1,541 $ 539 $ 24